As bstract. The effect of ketone bodies on glucose production (Ra) and utilization (Rd) was investigated in the 24-h starved, conscious unrestrained miniature pig. Infusing Na-DL-3-OH-butyrate (Na-DL-f-OHB) and thus shifting the blood pH from 7.40 to 7.56 resulted in a decrease of Ra by 52% and of Rd by 45%, as determined by the isotope dilution technique. Simultaneously, the concentrations of arterial insulin and glucagon were slightly enhanced, whereas the plasma levels of glucose, lactate, pyruvate, alanine, a-amino-N, and free fatty acids (FFA) were all reduced. Infusion ofNa-bicarbonate, which yielded a similar shift in blood pH, did not mimick these effects. Infusion of equimolar amounts of the ketoacid, yielding a blood pH of 7.35, induced similar metabolic alterations with respect to plasma glucose, Ra, Rd, and insulin; however, plasma alanine and a-amino-N increased.
Introduction
Ketotic hypoglycemia is the commonest variety of childhood hypoglycemia and accounts for 30-50% of the cases encountered in western clinical practice (1, 2) . It occurs not only in children, but also in adults (2) . Although it is known that ketotic hy-poglycemia is not a single disease entity, ketones have been proposed to be in some way causative for hypoglycemia. The infusion ofexogenous ketones has been widely used in searching for specific roles of ketone bodies in glucose homeostasis. Infusion of Na-DL-f3-OH-butyrate (Na-DL-/3-OHB)' reduced the rate of hepatic glucose production (3, 4, 5) as well as peripheral glucose uptake and oxidation (3, 5, 6) . As to the mechanism responsible for the decrease in hepatic gluconeogenesis, the following hypotheses have been put forward: (a) a diminished hepatic precursor, i.e., alanine supply, possibly due to the proposed protein sparing action of ketones (1, 2, 7, 8) ; (b) ketone body-induced insulin secretion (5, 9, 10) . With respect to the reduced muscular amino acid release, recent data demonstrate that the ketone-induced hypoalaninemic effect represents an experimental artifact related to the alkalinizing effect ofinfusing Na-DL-3-OHB (1 1). In fact, on infusing the free ketone acid, a rise in plasma alanine was observed; however, blood glucose decreased again (1 1).
On the other hand, the effect of insulin mediating the ketoneinduced hypoglycemia was questioned by some clinical data (1, 12, 13 ), e.g., the hypoglycemic action of Na-DL-(3-OHB also could be demonstrated in diabetics (14) .
The present paper sets out to investigate the physiological effect of ketone bodies on glucose homeostasis. Our data clearly demonstrate (a) that ketones inhibit hepatic gluconeogenesis, (b) that this effect is predominantly mediated by insulin and is independent of the alanine supply, (c) that the counterregulatory response to hypoglycemia is reduced by ketones, and (d) that the proposed protein-sparing action of ketone bodies represents an experimental artifact relating to the alkalinizing effect of Na-DL-OHB infusion.
Methods
Animals. 14 male castrated miniature pigs (specific pathogen free, 28-32 kg body wt, 12-mo-old) were purchased (Versuchsgut Domane Relliehausen, Gottingen, Federal Republic of Germany) about 4 wk before the experiments were started. The pigs were held under controlled conditions and kept on a standard chow diet as described previously (15, 16) .
Surgical procedures. For experiments in the conscious, unrestrained pigs, polyvinyl catheters were implanted into the aortic arch, the vena cava superior, and one venajugularis externa 8 d before the experiments (16) . The complete recovery from surgery was checked by standard laboratory parameters (16) . For measurement of liver and muscle metabolic balance, experiments were performed in five anaesthetized, 24-h starved miniature pigs. Anaesthesia was induced by intraperitoneal injection of 1.25 mg/lkg body wt azaperon (Stresnil, Janssen, GmbH, Dusseldorf, Federal Republic of Germany) and 10 mg/kg body weight metomidat (Hypnodil, Janssen) followed by intratracheal intubation; anaesthesia was maintained with N20/02 (3:1) and supplementary doses ofmetomidat (0.1 mg/kg body wt) as described (17) . In these experiments, polyvinyl catheters were inserted into the aortic arch, the vena cava 1 . Abbreviations used in this paper: Acac, acetoacetate; ,B-OHB, D-0-OH-butyrate; MCR, metabolic clearance rate; MCRG, MCR ofglucose; MCRK, MCR of ketones (ketones, sum of ,3-OHB plus Acac); Ra, rate of glucose production; Rd, rate of glucose utilization. superior, the vena jugularis externa, at the superior bulb of the vena jugularis interna, into the portal vein, the main stem of the hepatic vein of the left lobe, and via the right vena iliaca interna into the vena femoralis (16, 17) . After finishing the operative procedures, the abdomen was closed and experiments were started after a recovery period of 60 min. In these experiments, an increase in serum creatine kinase (up to 70 g/l) and lactate dehydrogenase (up to 240 u/1) was observed. At the end of the experiments, animals were sacrificed, and the position of all catheters was verified (16, 17) .
Experimental procedures. Experiments were performed after a starvation period of 24 h or up to 10 d. Labeled glucose was given via the vena cava superior, and all other substrates and hormones were given via vena jugularis externa. Patency of all catheters during the experiments was maintained by a constant infusion of 0.9% NaCI (0.1-0.2 ml/min);
between the experiments, catheters were filled up exactly with a heparin solution (0.1 U/kg body wt). A primed (20 MCi)/continuous (0.20 MCi/ min) infusion of [3-3H] glucose (I mCi/l ml; New England Nuclear Corp., Dreieich, Federal Republic of Germany) was begun to permit isotopic determination ofthe rates ofglucose production and utilization. Up to 120 min were allowed for isotope equilibration, steady state was reached usually between -20 min and 0 time as was reflected by the constancy in the concentration of labeled and unlabeled compounds in the blood. Na-DL-P-OHB (Sigma Chemicals, Munchen, Federal Republic of Germany) was prepared immediately before the experiments as a 4% solution (pH 9.20; osmolality, 940 mosmol/kg H20) in sterile Ringer solution (Na+, 147.2 mmol/liter; K+, 4.0 mmol/liter; Call, 2.25 mmol/ liter; C1-, 155.7 mmol/liter; osmolality, 289 mosmol/kg H20). Using different concentrations of Na-DL-#-OHB, a 2, 4, 8, 12, or 16 g/100 ml solution was prepared; the total infusion volume was 226 ml/180 min or 450 ml/360 min. In some experiments, the pH ofthe ketone solution was adjusted to 7.4, 6.0, or 5.0 by HC1 (0.1 M). The ketone solution was administered as a primed-constant infusion via a peristaltic infusion pump (Infusomat, Braun-Melsungen, Melsungen, Federal Republic of Germany). The priming dose was given over the initial 20-min period at twice the continuous infusion dose indicated in Figures and Tables. In order to produce increments in serum bicarbonate similar to that observed with the infusion of Na-DL-(B-OHB, sodium bicarbonate was infused into four pigs at a dose of 1.5 mmol/kg X body wt. In addition, insulin (porcine insulin, Hoechst, Frankfurt, Federal Republic of Germany) or cyclic somatostatin (stilamin, Serono, Freiburg, Federal Republic of Germany) were given in a 250 mg/100 ml albumin solution (total volume, 50 ml) (porcine albumin, Sigma Chemical Co.) to prevent adherence to glassware and tubing. L-alanine (Merck, Darmstadt, Federal Republic of Germany) was prepared as a 1 g/100 ml solution in sterile Ringer-Solution (pH 6.17; osmolality, 395 mosmol/kg H20). All solutions were passed through a 22-MM filter apparatus (Millipore G.m.b.H. NeuIsenburg, Federal Republic of Germany).
In long-term starvation experiments, pigs received Na-DL-(#-OHB or Na-bicarbonate as indicated in figures and tables. Simultaneously urine was collected in refrigerated containers and cumulative nitrogen excretion (sum of urea plus NW) was measured as described (15, 16) .
Hepatic blood flow was estimated in anaesthetized pigs using '33Xe washout kinetics as described (17) .
Analyticalprocedures. The methods for the determination ofstandard clinical and laboratory parameters, of glucose, lactate, pyruvate, glycerol, alanine, a-amino-N, free fatty acids (FFA), ofthe hormones insulin and glucagon, of pH, p02, and PCO2 as well as of the specific activity of glucose have been described in detail previously (15, 16, 18, 19 -(pVdc/dt), where c is the concentration of glucose, V represents the glucose distribution volume (calculated from the initial decline in the specific activity of glucose after the primed injection of the tracer), and p is the pool fraction (0.65 according to [21] ). Polynomial curves were fitted to the SA and plasma concentrations of glucose vs. time curves and a smoothing tricubic spline algorithm was used for this purpose on a TR 440 Telefunken computer. The evaluation of the rates of glucose turnover using the primed constant infusion and the pool fraction has been validated for the steady and the nonsteady state (22, 23) . The metabolic clearance rate (MCR) for glucose was calculated as the ratio of Rd to c that may reflect insulin-dependent glucose uptake, which is independent of the mass action of glucose. Recent data show that glucose uptake follows saturation kinetics. Thus, glucose clearance is not independent of plasma glucose concentration, indicating that the use of glucose clearance under some circumstances may be misleading (24, 25, 26) . The MCR of ketone bodies (MCRK) (the volume of blood irreversibly and completely cleared of ketone bodies) was calculated according to MCRK = Na-D-j3-OHB infusion rate/(X Ketone body concentration at equilibrium -basal ketone body concentration) (14) . This calculation is based on the assumptions (a) that the presence of the unphysiological L-isomer did not affect the metabolism of ketones, (b) that exogenous ketones are metabolized in a similar way to endogenous ketones, and (c) that during infusion of ketone bodies, the metabolic changes with respect to endogenous ketone body production are negligible under our experimental conditions. The clearance of total ketones was used since #-OHB is rapidly converted to Acac (see Results). Assuming steady state concentrations, ketone body utilization was calculated from MCR and steady state ketone concentration. As shown in Table III 2). On increasing the infusion of Na-DL-,B-OHB, plasma concentration increased to a new steady state level. Up to a serum concentration of 1. Effect of ketone body infusion on arterial metabolites and hormones ( Fig. 3) . Infusion of Na-DL-#-OHB resulted in a rapid drop in the serum FFA and glycerol concentration, whereas the levels ofplasma lactate, alanine, a-amino-N, and pyruvate (from 80 to 50 ,uM) showed a delayed decrease. Plasma lactate/pyruvate ratio was estimated to be 9 at zero time and showed only insignificant variations (from 8 to 10) during the infusion period. Arterial insulin and glucagon showed only small increases; however, the increases were pronounced when the portal concentrations were measured (see below and Fig. 7 ).
Effects ofketone body infusion on glucose turnover (Fig. 3 ). Infusion of Na-DL-13-OHB (15 gmol/kg X min) led to a drop in blood glucose, R. (-50%), and Rd (-45%). The effects were statistically significant at the beginning of the infusion period, and alterations were observed for up to 135 min perfusion time. The MCR for glucose was transiently reduced (5-60 min) (data not shown) despite the elevated plasma insulin levels. On infusing different amounts of Na-DL-P-OHB, similar decreases in blood glucose concentrations, R,, and Rd were observed (Table I) .
Effects of ketone body infusion at different pH (Table II) . In order to investigate whether ketone body-induced alteration in glucose homeostasis was due to the ketone-provoked shift in blood pH (compare Fig. 1 ), ketone solution was infused at different pH. The effect of infusing Na-DL-#-OHB (15 gmol/kg X min) at pH 9.2 (compare Fig. 3 ), 7.4j 6.0, or 5.0 was tested. At pH 5.0, blood pH decreased to 7.35 while a similar increase in plasma insulin and similar decline in glucose concentration, Ra, and Rd were observed. In contrast, plasma alanine level only declined after infusing Na-DL-j3-OHB at pH 9.2 (Fig. 3 ). Figure 3 . Effect of Na-DL-P-OHB infusion (15 Amol/kg X min, pH 9.2) on serum insulin, plasma glucagon, blood glucose, rate of glucose production (R.) and utilization (Rd), plasma FFA, glycerol, lactate, alanine, and a-Amino-N. For the ketone body level, compare Fig. 1 . The asterisks indicate levels of significance before and during infusion. *, P < 0.05; **, P < 0.01, n = 6. Effect of alkalinization of blood pH. Infusion of Na-DL-fl-OHB induced a shift of the pH to alkaline (compare with Fig.  1 ). Therefore, in control experiments, alkalinization of the blood pH was performed by infusing Na-bicarbonate (1.5 mmol/kg X min) to give a pH similar to that observed after infusion of Na-DL-#-OHB (compare Fig. 1 ). This infusion affected neither blood glucose concentration, Ra, Rd, nor the plasma levels of insulin, alanine, and ketones within 180-min perfusion time (data not shown). 2) plus L-alanine (1 umol/kg X min) for 180 min on plasma alanine, serum ketones (sum of (3-OHB plus Acac), and blood glucose.
Data given as means (n = 3).
Effect of ketone body plus alanine infusion (Fig. 4) . To investigate whether ketone body-induced hypoglycemia was due to a limited alanine supply, ketones were infused together with low amounts of alanine. This resulted in steady state levels for j3-OHB of -0.35 mM and for alanine of -0.5 mM. However, the supply of alanine did not prevent the ketone body-mediated decrease in blood glucose concentration.
Effect ofketone body plus insulin infusion (Fig. 5) . Ketone body-insulin interaction was investigated by the simultaneous infusion of ketones and insulin. Infusion of small amounts of insulin alone resulted in physiological insulin levels of -40 iLU/ml. Steady state plasma insulin levels were unaffected by or insulin plus Na-DL-,3-OHB (15 umol/kg X min, pH 9.2) (-, n = 4) on blood glucose, R., Rd, and MCR of glucose. The asterisks indicate levels of significance before and during infusion. *, P < 0.05, **,
the simultaneous infusion of Na-DL-#-OHB. This indicates that ketones did not affect the MCR of insulin (-20 ml/kg X min in the insulin-treated and insulin plus #-OHB-treated miniature pigs). Insulin at this infusion rate decreased blood glucose levels, and had pronounced effects on R. Only a minor, yet statistically significant reduction in R& was observed. The addition of ketones to the infusion of insulin had no additional effect on blood glucose, Ra, and Rd. Furthermore, ketone body steady concentration after #-OHB infusion (15 ,umol/kg X min) was identical in the presence and absence of insulin, indicating that insulin does not affect ketone body metabolic clearance rate.
Effect of ketone body plus somatostatin infusion (Fig. 6 ).
Somatostatin was infused in order to investigate further the ketone body-insulin interaction. As a result, insulin and glucagon declined in parallel; blood glucose showed an initial slight decrease which was followed by hyperglycemia between 100 and 180 min. This effect was due to the fall in Ra as well as Rd followed by a rise in Ra. In addition, MCR for glucose rapidly declined and plasma FFA, glycerol, alanine, and (3-OHB continuously increased. Infusing somatostatin plus Na-DL-#-OHB also resulted in hypoglycemia, which persisted during the whole infusion period with concomitantly reduced rates of Ra. Infusion of ketones in the somatostatin experiment had no further effect on the other parameters, i.e., glycerol, FFA, and MCR ofglucose.
Effect of ketone body infusion on liver, splanchnic, and leg metabolite balance (Fig. 7, Table III) . In order to investigate the ketone body-induced alterations in liver and muscle metabolism, experiments were repeated in five anaesthetized 24-h starved pigs by use of the catheter technique (compare with Methods). Infusing Na-DL-f3-OHB into these animals resulted in similar alterations in blood pH, bicarbonate, and other standard parameters as was observed for the non-anaesthetized pig (Fig. 1) . In addition, the concentrations of FFA, glycerol, aamino-N, alanine, and glucose were comparable in both experimental models, with the exception of lactate and ketones (Table III) . However, the higher steady state levels in arterial ketone bodies do not limit the conclusions, as it was shown that increasing the levels of circulating ketone bodies provokes similar alterations with respect to insulin and glucose turnover (compare Table I ). In addition, recent experiments in anaesthetized and conscious dogs lead to the conclusions that narcoticinduced changes in portal vein plasma flow do not affect hepatic extraction ofinsulin and glucagon (27) . Furthermore, anaesthesia and surgery did not alter basal insulin and glucagon or their secretion (e.g., induced by arginine) (27) .
The effect of Na-DL-(3-OHB infusion on arterial metabolite level as well as hepatic, splanchnic, and leg exchange is given in Table III Figure 7 . Effect of infusion of Na-DL-#-OHB ( (Fig. 7) . In addition, the hepatic insulin uptake was elevated during ketosis from 5 to 15 AgU/ ml (Fig. 7) . Since hepatic blood flow remained constant during ketosis, hepatic insulin extraction was also enhanced (Fig. 7) .
The fractional extraction of insulin increased from 23% in the basal period to -41% during the infusion period (data not shown).
Concomitantly, portal venous, hepatic venous, and arterial glucagon concentrations were elevated by ketone infusion; the hepatic gradient of glucagon was transiently increased (Fig. 7) . These Effect of ketone body infusion during prolonged starvation. Since a protein-sparing action of ketones has been proposed (8, 9) , which by decreasing precursor supply could contribute to the reduced hepatic output ofglucose, Na-DL-#-OHB was infused at pH 9.2 at the fourth, fifth, and sixth day of the starvation period. Blood pH increased (7. 45 to 7.56); blood glucose and plasma alanine values decreased (Fig. 8) . N-excretion was reduced mainly due to a decrease in NH4 -excretion.
Infusing Na-DL-#-OHB at pH 5.0 at the fourth, fifth, and sixth day of the starvation period decreased blood pH from 7.43 to 7.35, but increased urinary N-excretion, both as urea and as NH' (Fig. 9) .
On infusing Na-bicarbonate at the fourth, fifth, and sixth day of starvation, blood pH increased from 7.44 to 7.52, plasma glucose remained constant, and urinary N-excretion decreased ( Fig. 8 and 9 ).
identical increases in arterial insulin, and correspondingly, identical decreases in Ra (compare Results). No dose dependent relationship between ketone body level and inhibition ofRa was observed (Table I) . (c) Infusing physiological amounts ofinsulin together with Na-DL-(3-OHB did not exceed the ketone-induced reduction of gluconeogenesis (Fig. 5) . Nevertheless, assuming a direct effect of ketones, it may be possible that once Ra was reduced by insulin (Fig. 5) , ketone could not provoke a further reduction. In fact, ketones infused at insulinopenia (during somatostatin plus Na-DL-/3-OHB treatment) resulted in a significantly decreased Ra during the prolonged infusion time, which is possibly a direct action of ketones (Fig. 6) . A direct effect of ketones could involve the following mechanisms: the ketoneprovoked flux of pyruvate from glucose towards acetyl-Coenzyme A (CoA), as was demonstrated in the isolated perfused liver (28), and/or the ketone body-mediated reduction in FFA, which is suggested to stimulate hepatic gluconeogenesis. However, as ketones lowered Ra at constant levels of FFA (compare Table III ), this mechanism seems unlikely under our conditions. On infusing somatostatin, the late hyperglycemia (Fig. 6 , from 90-min infusion period) is considered to be due to an enhanced catecholamine secretion stimulating glucose production (29) . However, infusing somatostatin together with ketone bodies, the reduced rate of Ra persisted and consequently blood glucose decreased (Fig. 6) . As well as a direct effect of ketones (compare above), this may alternatively or additionally be the result ofthe ketone-induced reduction ofthe adrenergic response. In fact, it is known that ketotic hypoglycemic children display a diminished adrenal medullary response (1, 2, 30, 31 (Fig. 7) . Alterations in the arterial levels of this hormone were only small but nonetheless significant (Figs. 3 and 7 , Table II ). This is in accordance with the ketone-induced increase in arterial C-peptide level at simultaneously unaltered venous plasma insulin levels reported recently for man (5 Figure 9 . Effect of 6-h Na-DL-P-OHB infusion (15 (Fig. 3) . A similar in vivo finding was shown previously by other authors (3, 5, 6) . From in vitro data, it is known that Acac inhibits glucose uptake in rat soleus but not in extensor digitorum longus muscles or the perfused hindlimb of rats (32, 33) . Circulating insulin levels of -40 gU/ml primarily reduce Ra and thereby, the blood glucose level, whereas only minor effects on Rd are apparent (Fig. 5) 35) . This is supported by our data showing a ketone induced increase in portal insulin with a concomitant alteration of its hepatic extraction (Fig. 7) . Accordingly, in man, ketones provoked an increase in arterial C-peptide at simultaneously unchanged insulin levels (5) .
Only sparse data are available on the effect of ketones on a-cell secretion (35, 36) . Glucagon release from isolated guinea pig islets of Langerhans incubated in vitro was unaffected by ketones (37) . However, our in vivo data clearly demonstrate that physiological increases in serum ketones provoke a-cell secretion (Fig. 7) . This may be simply due to hypoglycemia. Thus, the a-cell response may be responsible for the recovery from hypoglycemia observed during ketone infusion (Fig. 3) (compare 38, 39). In fact, the latter idea is supported by the sustained hypoglycemia observed during simultaneous infusion ofsomatostatin and Na-DL-f3-OHB (Fig. 6) . Despite the increased glucagon secretion, hepatic fractional glucagon uptake remained nearly constant (Fig. 7) . This is similar to data observed after insulin, glucagon, arginine, or cholecystokinine infusion (40, 41) . On the other hand, hepatic glucagon extraction was enhanced in dogs after meat ingestion (42) suggesting that neural or hormonal signals from the gut may be involved in hepatic glucagon extraction (42) .
Ketone bodies and alanine. There are several lines ofevidence that the f3-OHB-mediated decrease in hepatic glucose output does not depend on alanine supply, as has been proposed by several authors (1, 7, 8, 14) : (a) Infusing the ketoacid resulted in an increase rather than a decrease in plasma alanine, nevertheless hypoglycemia occurred (compare Results). Using stable isotopes, Miles et (Table III) as well as arterial alanine concentration (Fig. 3) , hepatic extraction of alanine was not affected (Table III) . (c) Prevention of the ketone-induced hypoalaninemia by the simultaneous infusion of physiological amounts of alanine together with ,-OHB did not prevent hypoglycemia (Fig. 4) . However, it should be mentioned that using pharmacological amounts of alanine (2.8 mmol/kg body wt X 30 min), ketotic hypoglycemic children become euglycemic (1, 2) . (d) Ketone bodies decreased hepatic gluconeogenesis by -50%; plasma alanine levels decreased by only 25% (Fig. 3 , Table III ). (e) In the miniature pig, alanine contributes only -13% of splanchnic glucose output (16); consequently, any alteration in alanine extraction could not produce a fall in gluconeogenesis between 30 and 50%; (f) Considering urinary Nexcretion during starvation (Fig. 8) , -9 gmol N/kg X min were released accounting for 4.5 gmol glucose/kg X min, assuming a maximal conversion efficiency. However, Na-DL-(3-OHB decreased urinary N-excretion by 4 jsmol/kg X min (Fig. 9) , which is equivalent to maximally 2 ,mol/kg X min of glucose. Thus, the ketone-induced inhibition in amino acid conversion to glucose could not explain the decrease in Ra from 12 to 7 ,umol/ kg X min (Fig. 3) . (g) Infusion of somatostatin plus ,3-OHB resulted in an increase in circulating alanine; however, Ra decreased again (Fig. 6 ). (h) The ketone-induced decrease in glucose production preceeded hypoalaninemia (Fig. 3 , Table III ). In addition, recent data demonstrate that the initiation of a ketogenic diet in children produced hypoalaninemia independent of hypoglycemia (44) . As alanine flux is reported to be decreased in ketotic hypoglycemic children (1) , our data provide evidence that hypoglycemia and hypoalaninemia are independent metabolic events.
Role of "Alanine-Ketone Body Cycle. " The existence of an "Alanine-Ketone Body Cycle" has been proposed by some authors (45, 46) ; thus, the rise in serum ketone acids may represent a signal to muscle that increases alanine output and restricts hepatic ketogenesis, while gluconeogenesis is maintained (46, 11) . However, with respect to ketotic hypoglycemia, the regulatory significance of this cycle seems unlikely: keto-acids inhibited glucose production despite increasing alanine supply (Table III, Fig. 4) . However, the functional significance of the "Alanine-Ketone Body Cycle" in the presence of high levels of glucagon and the absence ofinsulin, e.g. diabetes mellitus, cannot be excluded by our experiments.
Regulatory role of blood lactate/pyruvate ratio for muscle alanine release. Recently, it was suggested (45) that a shift of muscle pyruvate towards lactate as reflected by alterations in the lactate/pyruvate ratio in the blood may represent an important mechanism responsible for the decrease of alanine in ketotic states. However, in our experiments at elevated plasma ketones and simultaneously reduced alanine levels (Fig. 3) , the blood lactate/pyruvate ratio was unaltered (compare Results). This finding questions the regulatory significance of the blood lactate/pyruvate ratio for reducing plasma alanine levels.
Protein sparing action of ketone bodies. As in man, in the miniature pig during starvation, hepatic ketogenesis and plasma ketones increase, whereas plasma glucose, alanine, and urinary N-excretion, an indicator of protein catabolism, decrease (15, 16) . During fasting, the protein sparing effect has been ascribed to the action of ketones (7, 8, 47) . Recently, Pawan and Semple (48) demonstrated a decrease in urinary-N and methyl-histidine excretion in obese fasted subjects when infusing minimal amounts of ketones (1.2 ,mol/kg body wt X min). In contrast, our data clearly demonstrate that the ketone-induced inhibition ofalanine release and reduction in urinary N-excretion represents an experimental artifact (Fig. 8) related to the alkalinizing effect of the sodium salt of #-OHB. Using equimolar amounts of the ketoacid, urinary N-excretion increases during the starvation period (Fig. 9 ). This could be due to the known protein wasting effect of acidosis leading to an increase in muscle alanine release (43, 49) . On the other hand alkali-treatment reduces urinary N-excretion in prolonged fasted subjects (50, 51) . Contrary to our data, it was reported that the infusion of sodium free ,B-OHB provoked a 50% decrease in renal ammoniogenesis in dogs (52) . Yet, it should be mentioned that the ketosis here (4.5 mM) differed from our experimental conditions (0.5-1 mM) and that NH' only contributes up to -10% of total N-excretion (compare with Fig. 8 ).
Taken together, ketone bodies inhibit endogenous glucose production, and thereby, provoke hypoglycemia. This effect is most probably mediated by insulin; however, a direct effect of ketones on hepatic gluconeogenesis may contribute to the observed phenomenon. Furthermore, a ketone body-induced de- crease in adrenergic response may maintain hypoglycemia. Ketotic hypoglycemia is not due to a limited alanine supply. Ketone-induced decrease in glucose utilization is most probably a consequence of decreased glucose production. In summary, our data offer a reasonable explanation for ketotic hypoglycemia and they demonstrate that ketones do not show a protein sparing action.
